NATERA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.45 USD | +1.28% |
|
+8.63% | +47.89% |
| Apr. 18 | Natera Insider Sold Shares Worth $7,265,651, According to a Recent SEC Filing | MT |
| Apr. 18 | Natera Insider Sold Shares Worth $634,797, According to a Recent SEC Filing | MT |
Chart calendar Natera, Inc.
4f05427404e91a18e3b.0h-wpTqlunySgkZFFGwA9SdTJ-XluhZ_ODR9i7INmY8.gSjanVvk0iXn4xMsfwJUpF8lU9fc0UkUSHIb3u13y9yCc4XtTeKONNXdIQ~d68ba68d2343a9533afb8a76e7cb52cf
Upcoming events on Natera, Inc.
Past events on Natera, Inc.
| 2024-03-17 04:45 pm | Society of Gynecologic Oncology Meeting - Mike Shalamov |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1274 |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1243 |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1242 |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1241 |
| 2024-03-17 04:15 pm | Society of Gynecologic Oncology Meeting - Poster Number - #1181 |
| 2024-03-16 05:15 pm | Society of Gynecologic Oncology Meeting - Anne Knisely |
| 2024-03-06 09:50 am | TD Cowen Health Care Conference |
| 2024-03-05 02:15 pm | Raymond James Institutional Investors Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number : 695 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number :6 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 23 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number :27 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number : 528 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 196 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number : 212 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number :183 |
| 2024-01-17 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number :54 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 302 297 1.84% | 391 385 1.5% | 625 621 0.64% | 820 819 0.12% | 1 083 1 054 2.72% | 1 340 |
|
EBITDA Million USD | Released Forecast Spread | -123 -128 3.69% | -208 -184 -13.03% | -457 -433 -5.42% | -524 -523 -0.18% | -422 -421 -0.32% | -262 |
|
EBIT Million USD | Released Forecast Spread | -131 -127 -2.87% | -216 -191 -13.13% | -468 -449 -4.27% | -541 -539 -0.32% | -446 -447 0.08% | -289 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -123 -132 7.15% | -230 -204 -12.44% | -471 -453 -4.06% | -547 -547 0.06% | -435 -440 1.27% | -280 |
|
Net income Million USD | Released Forecast Spread | -125 -131 4.96% | -230 -204 -12.64% | -472 -453 -4.15% | -548 -549 0.17% | -435 -440 1.18% | -280 |
|
EPS USD | Released Forecast Spread | -1,79 -1,90 5.99% | -2,84 -2,54 -11.94% | -5,21 -5,02 -3.81% | -5,57 -5,59 0.42% | -3,78 -3,85 1.9% | -2,32 |
| Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 173 169 2.63% | 194 177 9.92% | 198 194 2.34% | 211 207 1.93% | 217 216 0.81% | 242 227 6.3% | 261 242 8.23% | 268 259 3.55% | 311 287 8.28% | 316 | 328 | 339 | 356 | 373 |
|
EBITDA Million USD | Released Forecast Spread | -137 -113 -20.83% | -134 -147 8.76% | -138 -134 -3.67% | -114 -136 16.42% | -138 -135 -2.14% | -133 -121 -10.32% | -107 -112 4.14% | -104 -101 -2.62% | -77,6 -69,4 -11.83% | -90,9 | -75,3 | -65,9 | -54,3 | -39,3 |
|
EBIT Million USD | Released Forecast Spread | -140 -121 -15.45% | -137 -140 2.03% | -143 -143 0.26% | -119 -139 14.06% | -142 -140 -1.03% | -138 -125 -10.69% | -112 -120 6.37% | -111 -109 -1.91% | -84,5 -84,4 -0.19% | -86,7 | -77,7 | -68,7 | -56,8 | -54,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -141 -123 -14.21% | -138 -143 2.92% | -145 -145 -0.04% | -121 -142 14.56% | -142 -143 0.36% | -137 -129 -5.9% | -111 -123 9.45% | -109 -111 1.65% | -77,8 -83,3 6.52% | -86,6 | -76,8 | -67,0 | -54,0 | -52,5 |
|
Net income Million USD | Released Forecast Spread | -141 -123 -14.59% | -139 -142 2.26% | -145 -145 0.11% | -121 -142 14.44% | -143 -144 1.13% | -137 -128 -6.67% | -111 -122 9.39% | -109 -110 0.89% | -78,0 -83,3 6.38% | -86,0 | -75,6 | -65,9 | -53,8 | -52,6 |
|
EPS USD | Released Forecast Spread | -1,49 -1,30 -14.91% | -1,45 -1,49 2.67% | -1,50 -1,50 0.05% | -1,25 -1,45 13.86% | -1,37 -1,42 3.44% | -1,23 -1,16 -5.9% | -0,97 -1,08 10.53% | -0,95 -0,96 0.81% | -0,64 -0,71 9.44% | -0,72 | -0,63 | -0,55 | -0,44 | -0,42 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 03/08/23 | 08/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Natera, Inc.
| Today 01:45 am | MEDICOVER AB: Q1 2024 Earnings Release |
| Today | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
| Today | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
| 2024-04-25 06:58 am | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| 2024-04-24 09:09 pm | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| 2024-04-24 | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 2024-04-24 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-24 04:16 pm | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-04-24 04:15 pm | CHEMED CORPORATION: Q1 2024 Earnings Release |
| 2024-04-24 02:00 am | ATTENDO AB: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NTRA Stock
- Calendar Natera, Inc.
